Skip to main content

Table 5 Predictors for the incidence of MACCEs in patients with new-onset NSTEMI

From: Serum total bilirubin and long-term prognosis of patients with new-onset non-ST elevation myocardial infarction: a cohort study

Variables

Univariate analysis

Multivariate analysis

HR

95% HR

p value

HR

95% CI

p value

Female, n (%)

0.533

0.287–0.991

0.047

0.598

0.319–1.121

0.109

Age (years)

1.011

0.987–1.035

0.387

   

Hypertension, n (%)

1.774

1.044–3.012

0.034

1.296

0.742–2.261

0.362

Diabetes mellitus, n (%)

2.130

1.259–3.602

0.005

1.800

1.041–3.113

0.035

Current Smoking, n (%)

1.211

0.720–2.036

0.470

   

SBP (mmHg)

1.001

0.988–1.014

0.860

   

DBP (mmHg)

0.992

0.969–1.015

0.480

   

BMI (kg/m2)

0.958

0.892–1.029

0.237

   

HDL-C (mmol/L)

0.517

0.190–1.405

0.196

   

LDL-C (mmol/L)

0.891

0.685–1.158

0.388

   

TC (mmol/L)

0.956

0.777–1.175

0.667

   

TG (mmol/l)

1.001

0.937–1.068

0.996

   

ApoA1 (g/L)

0.736

0.311–1.741

0.485

   

ApoB (g/L)

0.676

0.284–1.610

0.377

   

Creatinine (mmol/L)

0.995

0.984–1.006

0.390

   

BUN (mmol/l)

0.943

0.818–1.086

0.412

   

Uric acid (mmol/L)

0.998

0.996–1.001

0.299

   

CK-MB (U/L)

1.001

0.998–1.002

0.674

   

Troponin T (μg/L)

1.232

1.057–1.435

0.007

1.172

1.007–1.365

0.040

TBIL tertiles

      

 2nd tertile vs 1st tertile

3.653

1.566–8.518

0.003

2.737

1.161–6.450

0.021

 3rd tertile vs 1st tertile

4.555

1.983–10.465

< 0.001

3.272

1.408–7.607

0.006

LVEF (%)

0.986

0.942–1.032

0.542

   

LVEDD (mm)

0.990

0.921–1.066

0.797

   

Killip class

0.953

0.570–1.595

0.855

   

GRACE Score

0.997

0.989–1.006

0.551

   

CRUSADE Score

0.996

0.979–1.013

0.635

   

SYNTAX tertiles

      

 2nd tertile vs 1st tertile

3.40

1.366–8.469

0.009

2.767

1.097–6.980

0.031

 3rd tertile vs 1st tertile

5.214

2.175–12.498

< 0.001

3.165

1.280–7.827

0.013

UPLMT, n (%)

2.932

1.641–5.240

< 0.001

2.042

1.063–3.923

0.032

PCI, n (%)

1.329

0.726–2.435

0.357

   

Medications after discharge

      

 Aspirin, n (%)

3.097

0.429–22.380

0.263

   

 Clopidogrel, n (%)

2.820

0.687–11.586

0.150

   

 Statins, n (%)

2.298

0.561–9.423

0.248

   

 β-Blockers, n (%)

1.330

0.671–2.633

0.414

   

 ACEI/ARB, n (%)

1.119

0.612–2.045

0.715

   

 CCB, n (%)

1.111

0.561–2.202

0.762

   
  1. Values of p < 0.05 are indicated in bold. All abbreviations are presented in Table 1
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us